Fitch Solutions
Fitch Solutions provides crucial intelligence to help its clients understand and interpret markets, so they can protect their organisations’ interests and help to grow profitability.
Outlook uncertain for India’s generic drug makers: Fitch
The country is expected to retain its position as ‘pharmacy of the world’ despite challenges.
Outlook uncertain for India’s generic drug makers: Fitch
The country is expected to retain its position as ‘pharmacy of the world’ despite challenges.
SG medical device market to generate a CAGR of 7.4% from 2022-2027
The market will reach $1.4b (USD1.1b) by 2027.
Slow GDP growth in UAE to hit medical device market
The medical device market will be constrained by the slowdown in economic growth.
Malaysia’s healthcare spending to see 7.7% rise in five years: Fitch
Reforms are also eyed to ensure sustainable financing in the long run.
Private sector spending seen driving UAE’s healthcare system
The private sector is playing an increasingly important role in the country’s healthcare system.
Ageing population, tech drive Japan’s medical device market
The country is already home to the highest senior population ratio in the world.
Singapore health costs to decline this year but still higher than 2019: Fitch
Health expenditure declined from $17.b in 2022.
Foreign players to play key role in China's cardiovascular disease approach
The country is heavily reliant on foreign players in CVD management.
India eyes database on drug formulations in the country
This will help address issues on the quality of drugs in the market, Fitch Solutions said.
Healthcare budget boost to beef up Australia’s pharma sector
The allocation is expected to help reduce the pressure on the hospital system.
Opportunities for drugmakers in Cambodia limited despite rising diseases
Low government funding has affected the quality of healthcare in public hospitals.
India locally develops 35 previously imported pharma ingredients
The country is expected to remain keen to lessen pharma import dependency.
Australia expands digital initiatives in COVID-19 response
The country’s pandemic landscape is expected to transform further in the coming months.
Digital healthcare demand to rise in India: report
The structural shift in the country’s healthcare system has been influenced by tech.
New Zealand’s medicines budget to boost R&D-based drugmakers
But Fitch Solutions’ report noted that allocation for medicine investment remains low.
Rise in Indian medicine exports may cause patent woes in Australia: Fitch
India's weak IP laws could be an issue for drug manufacturers in Australia.
Malaysian health expenditure to reach MYR91.1b in 2025: Fitch
The 2021 healthcare budget allocation is at MYR31.9b.